期刊文献+

乙肝患者肝组织中HBVcccDNA与血清中HBVDNA、HBeAg的关系 被引量:7

Liver Tissue CCCDNA and Serum HBV DNA,HBeAg in Patients with Hepatitis B Correlation Between
下载PDF
导出
摘要 目的探讨乙肝患者肝组织中HBVcccDNA与血清中HBVDNA、HBeAg的关系。方法采用实时荧光定量聚合酶链反应检测乙肝患者肝组织中HBVcccDNA及血清HBVDNA,同时采用ELISA检测其血清中免疫指标HBeAg。结果30例HB-sAg、HBeAg、抗HBc阳性的乙肝患者血清中HBVDNA阳性28例阳性率93.33%,肝组织中HBVcccDNA阳性19例阳性率63.33%,两者比较差异有显著性P<0.05。30例HBsAg、抗HBe、抗HBc阳性的乙肝患者血清中HBVDNA阳性8例阳性率26.67%,肝组织中HBVcccDNA阳性5例阳性率16.67%,两者比较差异无显著性P>0.05。10例脂肪肝患者血清HBVDNA阴性,肝组织中未检出HBVcccDNA。结论(1)血清HBVDNA或HBeAg阳性并不能完全确定肝内一定存在乙肝病毒正在复制。(2)HBeAg阴性抗HBe阳性不能完全确定肝内一定没有乙肝病毒复制。(3)要确定肝内病毒是否存在复制必须通过肝组织HB-VcccDNA检测来证实。 Objective To explore the correlation between liver tissue cccDNA and serum HBV DNA, HBeAg in patients with hepatitis. Methods Hepatitis B patients liver tissue cccDNA and serum HBV DNA were defected by Real - time fluorescence quantitative polymerase chain reaction,while immune parameters of HBeAg in Serum was defeefed by ELISA. Results Of 30 cases of HBsAg, HBeAg, anti- HBc- positive hepatitis B patients, positive HBV DNA in serum was 28 cases, positive rate 93.33% ; 19 cases, positive rate 63. 33% , the difference between the two is significant ( P 〈 0.05 ). of 30 cases of HBsAg, anti - HBe, anti - HBc hepatitis B patients, positive HBVDNA in serum was eight cases with postive rate 26. 67% ; positive HBVcccDNA in liver tissne was five cases with positive rate 16.67% , the difference between the two was not significant (P 〉0.05) of 10 cases of patients with fatty liver,serum HBV DNA was negative. Conclusions ( 1 ) HBVDNA occured in serum of positive HBeAg was not necesarily to have virus replication ; (2) negative HBeAg or anti HBe was not necesqrily to deny virus replication ; (3) to determine whether the vivus is replicated or not, it showld be confirmed by detection of HBV cccDNA in liver fissue.
出处 《医学研究杂志》 2008年第3期60-61,共2页 Journal of Medical Research
基金 杭州市科技局科研项目(2004433Q03) 杭州市卫生局重点传染专科课题
关键词 肝组织 乙肝病毒共价闭合环状DNA 荧光定量聚合酶链反应 Liver tissue cccDNA Fluorescence quantitative polymerase chain reaction
  • 相关文献

参考文献4

  • 1Chen Y,Sze J,He ML. HBV cccDNA in patients sera as an indieat for HBV reaetivation and an early signal of liver damage[J].World Gastroenteml,2004 ,10 :82 - 88
  • 2Werle - Lapos O B, Bowden , Lo amini , et al. Persis enee of DNA CCCDNA during the natural history of ehronie hepatitis B and deeline during adefovir adipivoxil therapy [ J ]. Gastroenterology, 2004, 126 : 1750 - 1758
  • 3Wong DK, Yuen MF, Yuan H,et al, Quantitation of covalently closed circular hepatitis B Viras DNA in chronic hepatitis B Patients[J].Hepatology,2004,40:727 - 737
  • 4赵克开,缪晓辉,徐文胜.HepG2.2.15细胞内乙型肝炎病毒cccDNA的定量检测[J].中华传染病杂志,2005,23(1):6-9. 被引量:23

二级参考文献7

  • 1Lu X, Block TM, Gerlich WH. Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J Virol,1996, 70:2277-2285.
  • 2Addison WR, Walters KA, Wong WW, et al. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol, 2002, 76:6356-6363.
  • 3He ML, Wu J, Chen Y, et al. A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commun, 2002, 295:1102-1107.
  • 4Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci, 1987, 84:1005-1009.
  • 5Sells MA, Zelent AZ, Shvartsman M, et al. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol, 1988, 62:2836-2844.
  • 6Lampertico P, Malter JS, Gerber MA. Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics. Hepatology, 1991, 13:422-426.
  • 7黄砚青 龚作炯 张希惠.乙型肝炎病毒共价闭合环状DNA的特异性检测[J].肝脏,2001,6:38-39.

共引文献22

同被引文献79

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部